This inventor holds 9 USPTO granted patents and 4 published patent applications, plus 6 CIPO patents and 7 EPO patents. Top assignees: Itm Isotopen Technologien Munchen Ag, Itm Isotope Technologies Munich Se, Johannes Gutenberg-Universität Mainz. Active years: 2012-2023.
Location History:
- Garching, DE (2012 - 2017)
- München, DE (2017)
- Munich, DE (2013 - 2023)
Company Filing History:
6 out of 8 
2 out of 3 
1 out of 45 
Years Active: 2012-2023
As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I am here to help you with information about inventor Konstantin Zhernosekov.
Title: Konstantin Zhernosekov: Revolutionizing Radiopharmaceuticals in Munich
Introduction: Konstantin Zhernosekov, a prolific inventor based in Munich, Germany, has made significant contributions to the field of radiopharmaceuticals through his innovative patents.
Latest Patents:
1. **PSMA-binding agents and uses thereof:** This patent introduces novel compounds for radiopharmaceuticals, imaging agents, and cancer treatment.
2. **Method for the manufacture of highly purified 68Ge material:** A groundbreaking method for producing purifiedGe material for radiopharmaceutical purposes, meeting GMP standards.
Career Highlights: Zhernosekov has showcased his expertise in companies like ITM Isotopen Technologien München AG, where he has played a pivotal role in advancing radiopharmaceutical research.
Collaborations: Alongside talented coworkers like Tuomo Nikula and Mark Harfensteller, Zhernosekov has been able to harness collective intelligence to drive innovation in the field.
Conclusion: Konstantin Zhernosekov's dedication to revolutionizing radiopharmaceuticals through cutting-edge inventions underscores his commitment to advancing healthcare. His patents stand as a testament to his ingenuity and impact on the industry.